B

$XTALPI(02228.HK) Discussing risks at a stage peak. My personal view is that PharmaTech's fundamentals currently appear …

$XTALPI(02228.HK) Discussing risks at a stage peak. My personal view is that PharmaTech's fundamentals currently appear sound, and a continued bullish stance based on fundamentals is justified. The biggest risk stems from the source of liquidity. Overall, the liquidity and stock price of PharmaTech are undoubtedly supported by funds from the A-share market. Therefore, from a certain perspective, the sentiment in the A-share market is a crucial support for the stock price at this stage. Of course, we are fortunate to witness the start of a historic slow bull market just as fundamentals have significantly improved. The current pace suggests we are still in the early to mid-stages of the bull market (frankly, I’ve been feeling a bit restless lately, wanting to grow my RMB holdings—seeing my deposits at China Merchants Bank not increasing makes me anxious). However, given the rhythm of the A-share market and the habits of retail investors, confidence in a long-term slow bull market is lacking. How long can this last? Six months? Until Q1 or Q2 next year? Will it? Could the A-share market become overly aggressive, leading to massive bubbles and a rush for the exits? From my current perspective, this is the biggest macro risk PharmaTech faces in the medium term. When market sentiment shifts, investors won’t consider fundamentals—they’ll just want to preserve cash... This is the stampede effect.

MEDIUM HIGH LCW RISK 人 安全客(www.anquanke.com)

The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Author's posts

View more
  • Summary of short positions on RKLB and TSLA

    By Grok, based on the 'float ratio', RKLB is much more volatile than Tesla; in USD nominal terms, Tesla's short interest is larger...

    9 likes
  • FY2024 Earnings Interpretation by Jason

    $ XTALPI.HK Conclusion: This earnings report reflects 'improved operating structure but deteriorating financial quality.' It is not a thesis break, nor is it a pretty report. The most valuable change is that AI4S has evolved from a narrative to a business contributing nearly half of revenue; the most dangerous change is that growth is increasingly reliant on low-margin, heavy-delivery robotic labs and substantial R&D spending. Let's break down the headline H1 revenue **RMB 393.6mn (-23.9% YoY)**; net loss attributable to parent RMB 251.9mn...

  • Mr. Zhou's technical analysis of 2228.HK

    Regarding the interpretation of Mr. Zhou's $ XTALPI.HK chart: Jason: Understandable. The core of this friend's chart is not the complex indicators themselves, but rather expressing a relatively clear technical view: 2228 has emerged from a long-term downtrend and is undergoing a bottom reversal; 7.9–8.0 is the first breakout level, and 9.5–10 is the main resistance zone. I break down the chart into several layers: 1. Descending Wedge Breakout The two blue descending trendlines in the chart form a structure similar to a descending wedge / converging downtrend channel. His point is: it fell all the way from last year's high...